THORNE DIAGNOSTICS INC.

Company Snapshot

Entity Type: Private
Region: U.S.
Headquarter: Massachusetts, U.S.
Key Geographics: U.S.
Corporate Address: 100 Cummings Center, Suite 465E, Beverly, Massachusetts 01915 U.S. Tel. +1-978-921-2050 www.thornediagnostics.com

Company Overview

Thorne has developed a gel-based single-cell analysis platform that can detect genomic and proteomic differences in single cells. The company is a DNA technology-based company which aims to develop products that can fundamentally improve drug discovery and the practice of medicine. The company’s RAM (Ramification Amplification Method), single-temperature (isothermal) detection platform can increase discrimination power up to 1,000-fold above current methods. Application of RAM enables more sensitive detection of proteins with a much wider dynamic range.

The platform uses Thorne’s Ramification Amplification Method/Hybridization Signal Amplification Method (RAM/HSAM) technologies.

THORNE DIAGNOSTICS INC. In Reports

Proteomics: Technologies and Global Markets

Global proteomics market should reach $55.1 billion by 2027 from $27.1 billion in 2022 at a CAGR of 15.3% for the forecast period of 2022 to 2027.

Renewable Energy: Technologies and Global Markets

Global renewable energy market should reach $1,500 billion by 2027 from $932.3 billion in 2022 at a CAGR of 10.0% for the forecast period of 2022-27.

Renewable Energy: Technologies and Global Markets

The global market for renewable energy (excluding biofuels) should grow from $636.1 billion in 2018 to reach $855.2 billion by 2023 at a compound annual growth rate of 6.1% for the period of 2018-2023. ...

Company's Business Segments

  • Product : Clinical Health Tests, Ramification Amplification Technology, Hybridization Signal Amplification Technology, Others
  • Service : Research and Development, Lab Tests, Others

Applications/End User Industries

  • Healthcare
  • Diagnostics
  • Life Sciences
AI Sentiment